We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Solvonis Therapeutics Plc (SVNS) ORD GBP0.001

Sell:0.18p Buy:0.20p 0 Change: 0.02p (9.52%)
Market closed |  Prices as at close on 22 January 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.18p
Buy:0.20p
Change: 0.02p (9.52%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 22 January 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.18p
Buy:0.20p
Change: 0.02p (9.52%)
Market closed |  Prices as at close on 22 January 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Solvonis Therapeutics PLC, formerly Graft Polymer (UK) PLC, is a United Kingdom-based biotechnology company. The Company is focused on developing intellectual property related to the treatment of mental health and substance-use disorders, and co-developing therapeutics for these conditions. It focuses on improving outcomes for individuals suffering from these disorders, with an initial focus on trauma-related mental health conditions, such as PTSD. PTSD is a debilitating mental health condition characterized by persistent and distressing symptoms following exposure to traumatic events.

Contact details

Address:
Eccleston Yards, 25 Eccleston Place
LONDON
SW1W 9NF
United Kingdom
Telephone:
+ (0)
Website:
https://graftpolymer.co.uk/

Important dates

Future events
There are no future events available.
Past events
General meeting 06 January 2025 06/01/25

General stock information

EPIC:
SVNS
ISIN:
GB00BMD1Z199
Market cap:
£4.36 million
Shares in issue:
2.30 billion
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Anthony Tennyson
    Chief Executive Officer, Executive Director
  • Pavel Kobzev
    Chief Marketing Officer
  • Anthony Eastman
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.